Cover
Cover | Feb. 03, 2022 |
Cover [Abstract] | |
Document Type | 8-K/A |
Document Period End Date | Feb. 3, 2022 |
Entity Registrant Name | Quest Diagnostics Inc |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-12215 |
Entity Tax Identification Number | 16-1387862 |
Entity Address, Address Line One | 500 Plaza Drive |
Entity Address, City or Town | Secaucus, |
Entity Address, State or Province | NJ |
Entity Address, Postal Zip Code | 07094 |
City Area Code | (973) |
Local Phone Number | 520-2700 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, $0.01 Par Value |
Trading Symbol | DGX |
Security Exchange Name | NYSE |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0001022079 |
Amendment Flag | true |
Amendment Description | This Current Report on Form 8-K/A amends an Original Report on Form 8-K to provide information about compensatory arrangements entered into in connection with the appointment of Mr. James E. Davis as Chief Executive Officer–Elect. |